During this webinar, we will provide a background on biosimilar products, then discuss important industry updates, including changes in biosimilar adoption rates, the 2025 biosimilar pipeline, and FDA interchangeability requirements.
‍
Autoimmune drugs are most employer's top spend category. This webinar will help the audience better understand the biosimilar pipeline, many of which are autoimmune drugs.

‍